|
[Conclusions]
Literature published by Oct. 31, 2004 concerning epidemiology of
endocrine disruptors and prostatic cancer was surveyed. The
results of the two cohort studies on atrazine did not agree and
thus did not permit conclusion on the relevance. Epidemiologic
studies on endocrine disruptors in relation to prostatic cancer
are few, and do not permit evaluation of causality at present.
Substances other than organochlorine compounds have not been
studied in this context. No Japanese subject has been studied.
Experimental designs with high reliability are needed for future
studies on this problem.
[Literature]
Table 2.4.1: Cohort studies on the relationship of endocrine disruptors with prostatic cancer
|
